Evidence map›Paper›PMID 34404689›Full record

ArticleRespiratory care2021

F

Sarah J Chalmers, Yewande E Odeyemi, Amos Lal, Heyi Li, Ryan D Frank, Ognjen Gajic, Hemang Yadav

Open access · bronzeAbstract read
In one paragraph

Article in Respiratory care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sarah J ChalmersDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic-Rochester, Rochester, Minnesota. chalmers.sarah@mayo.edu.
Yewande E OdeyemiDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic-Rochester, Rochester, Minnesota.
Amos LalDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic-Rochester, Rochester, Minnesota.
Heyi LiDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic-Rochester, Rochester, Minnesota.
Ryan D FrankDivision of Biomedical Statistics and Informatics, Mayo Clinic-Rochester, Rochester, Minnesota.
Ognjen GajicDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic-Rochester, Rochester, Minnesota.
Hemang YadavDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic-Rochester, Rochester, Minnesota.
Mayo Clinic · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
NCATS NIH HHS UL1 TR002377
6 · The paper itself

Abstract

backgroundSeveral markers of oxygenation are used as prognostic markers in acute hypoxemic respiratory failure. Real-world use is limited by the need for invasive measurements and unreliable availability in the electronic health record. A pragmatic, reliable, and accurate marker of acute hypoxemic respiratory failure is needed to facilitate epidemiologic studies, clinical trials, and shared decision-making with patients. [Formula: see text] is easily obtained at the bedside and from the electronic health record. The [Formula: see text] trajectory may be a valuable marker of recovery in patients with acute hypoxemic respiratory failure.

methodsThis was a historical cohort study of adult subjects admitted to an ICU with acute hypoxemic respiratory failure secondary to community-acquired pneumonia and/or ARDS.

resultsOur study included 2,670 subjects. [Formula: see text] and [Formula: see text] were consistently more available than was [Formula: see text] in the electronic health record: ([Formula: see text] vs [Formula: see text] vs [Formula: see text] : 100 vs 100 vs 72.8% on day 1, and 100 vs 99 vs 21% on day 5). A worsening [Formula: see text] trajectory was associated with reduced ventilator-free days. From days 2 to 5, every increase in [Formula: see text] by 10% from the previous day was associated with fewer ventilator-free days (on day 2: adjusted mean -1.25 [95% CI -1.45 to -1.05] d,

conclusions[Formula: see text] and [Formula: see text] are pragmatic and readily available intermediate prognostic markers in acute hypoxic respiratory failure. The [Formula: see text] trajectory in the first 5 d of ICU admission provided important prognostic information (ventilator-free days). Although the [Formula: see text] trajectory was also associated with ventilator-free days, it did not provide more information than the [Formula: see text] trajectory alone.

Indexed as

Respiratory Distress SyndromeRespiratory InsufficiencyAdultCohort StudiesHumansHypoxiaVentilators, Mechanicalacute hypoxic respiratory failureacute respiratory distress syndromeelectronic health recordhypoxiapneumoniaprognosis

Identifiers

PMID34404689
PMCPMC9993558
OpenAlexW3194656978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.